1Lehmann JM, Moore LB, Smity-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferactor-activated receptor γ.J Biol Chem 1995;270:129 - 153.
2Hallakou S, Doare L, Foufelle F, et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes1997;46:1393 - 1399.
3Kemnitz JW. Elson DF, Roecker EB, et al. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes 1994;43:204-211.
4Rosenblatt S, Miskin B, Glazer NB, et al. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coron Artery Dis 2001; 12:413 - 423.
2World Health Organization. diabetes Mellitus. Report of a WHO study Group. Geneva World Health Organization. 1985 ;727.
3Chung E, Aldom JE, Carreno RA, et al. PCR-based quantitation of Cryptosporidium parvum in municipal water samples. Journal of Microbiological Methods. 1999 ;38 (1-2) : 119 - 130.
4Muyzer G, de Waal E, Uitterlinden A. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes encoding for 16S rDNA. Applied and Environmental Microbiology, 1993 ; 59 : 695 - 700.
